This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Patton, J. Search for Related Content PubMed Articles by Patton, J.

Increased Use of Oral Chemotherapy Drugs Spurs Increased Attention to Patient Compliance

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Ensuring that patients with breast cancer are taking the oral aromatase inhibitors (AIs) prescribed as follow-up treatment to surgery is an ongoing concern for oncologists, who lose control of medication administration when it moves from the office or hospital setting to the patient's home. Patients with breast cancer who are receiving AIs are to take them for 5 years after initial treatment for optimal efficacy. Partridge et al¹ have demonstrated that initial research reveals "patients prefer oral to IV [intravenous] chemotherapy, so long as efficacy isn't compromised." Convenience is the main reason given for this preference.

Patient compliance is a . . . [Click for More]